Dr. Paul M. Rougraff, MD

Dr. Rougraff practices at Naples Eye Physicians, PA in Naples, Florida.

Dr. Rougraff's NPI, 1831176288, was assigned on December 28, 2005. Dr. Rougraff graduated from Indiana University School Of Medicine in 1991. Dr. Rougraff holds Florida license ME63864.

Dr. Rougraff's primary practice is Naples Eye Physicians, PA, at 661 Goodlette N Rd, Naples, FL 34102 in Collier County. The practice phone is (239) 262-6288.

Dr. Rougraff's primary practice is Naples Eye Physicians, PA in Naples, Florida. Dmand AI also links Dr. Rougraff to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rougraff practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rougraff's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rougraff is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rougraff's licenses on file in 2 states: Florida and Indiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Rougraff treats.

CMS data shows 5,146 Medicare services from Dr. Rougraff across 21 procedure codes in 2024, for 2,341 Medicare patients. Medicare paid $406,961 for them.

CMS counts 2,341 Medicare patients who saw Dr. Rougraff in 2024. The largest group is 75 to 84, with 1,102 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rougraff's median patient age at 75, with 53% women.

In 2024, Dr. Rougraff wrote 2,236 Medicare Part D claims for 641 patients. 69% of them were for generic drugs. CMS names the drug for 2,132 of them, across 17 drugs with 11 or more claims each, at $127,314 in total drug cost. In 2023, CMS named 2,253 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rougraff for performance year 2024, reported as part of a group. Dr. Rougraff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 180 procedures of cataract surgery by Dr. Rougraff, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Rougraff. The most frequent topics are Amino Acid Sequence, Liver and Molecular Sequence Data. Dr. Rougraff has published most often in J Biol Chem. Dr. Rougraff's most frequent co-authors are Thomas E. Johnson, MD and David T. Tse, MD.

CMS Open Payments shows 55 general payments to Dr. Rougraff from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $829.

Dmand AI lists 2 awards for Dr. Rougraff.

Dr. Rougraff graduated from Indiana University School Of Medicine in 1991. Dr. Rougraff is a member of AAO.

Dr. Rougraff is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.